| Entity | Document Type | Tax ID |
|---|---|---|
| Cancer Care, Inc. | Consolidated Audited Financial Statements | Multiple |
| Cancer Care, Inc. | IRS Form 990 | 13-1825919 |
| Cancer Care Co-Payment Assistance Foundation, Inc. | IRS Form 990 | 25-1196709 |
|
Entity: Cancer Care, Inc. Document Type: Consolidated Audited Financial Statements Tax ID: Multiple |
|
Entity: Cancer Care, Inc. Document Type: IRS Form 990 Tax ID: 13-1825919 |
|
Entity: Cancer Care Co-Payment Assistance Foundation, Inc. Document Type: IRS Form 990 Tax ID: 25-1196709 |
| Name | Title | Compensation | |
|---|---|---|---|
| 1 | Patricia Goldsmith | Past Chief Executive Officer | $493,721 |
| 2 | Christine Verini | Chief Executive Officer | $408,486 |
| 3 | John Rutigliano | Chief Financial and Compliance Officer | $366,888 |
|
1 Name: Patricia Goldsmith Title: Past Chief Executive Officer Compensation: $493,721 |
|
2 Name: Christine Verini Title: Chief Executive Officer Compensation: $408,486 |
|
3 Name: John Rutigliano Title: Chief Financial and Compliance Officer Compensation: $366,888 |
CharityWatch's rating of Cancer Care also includes the financial activities of Cancer Care Co-Payment Assistance Foundation, which are consolidated in the Cancer Care audited financial statements for the fiscal year ended June 30, 2024. Each entity is organized as a 501(c)(3) public charity. All intercompany transactions have been eliminated in the audit consolidation.
"...On July 23, 2007, Cancer Care incorporated the Cancer Care Co-Payment Assistance Foundation, Inc. (the Co-Pay Foundation)...The primary function of the Co-Pay Foundation is to provide financial assistance to individuals with cancer in the form of co-payment assistance for both prescribed treatment and supporting medications, premium assistance, or other direct financial assistance in order to ensure access to care, treatment, and prescribed medications..." |
According to the Cancer Care consolidated audit of June 30, 2024 (Note 1(e) re: Contributed Goods and Services), Cancer Care received contributed goods and services in fiscal 2024 on which it placed a total value of $1,400,782. [Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.] |
According to the Cancer Care consolidated audit of June 30, 2024 (Note 1(d) re: Contributions), the Organization reports receiving approximately $58.5 million in "Contributions from the five largest donors," representing 81% of total contributions, in fiscal 2024. |
According to the Cancer Care tax filing for the fiscal year ended June 30, 2024, Cancer Care reports re: Compensation, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II): Cancer Care reports providing "bonus & incentive compensation" to five individuals during 2023. Patricia Goldsmith, Past Chief Executive Officer, received $65,000 of bonus and incentive compensation, with total reported compensation of $493,721. The remaining four individuals received between $250 to $40,000, with total reported compensation ranging from $188,377 to $408,486. According to the Cancer Care Co-Payment Assistance Foundation, Inc. tax filing for the fiscal year ended June 30, 2024, the Foundation reports re: Compensation, Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (IRS Form 990, Schedule J, Part II): In addition to the above "bonus & incentive compensation" payments provided by Cancer Care, the Foundation reports providing bonus and incentive compensation during 2023 in the amount of $10,750 to Michelle McCourt, Executive Director of Co-Pay Assistance. McCourt's total reported compensation during 2023 was $253,987. |
According to the Cancer Care 2024 tax filing: "Flavio and Renata Figueiredo - Family Relationship" (IRS Form 990, Schedule O re: Form 990, Part VI, Section A, line 2). Flavio Figueiredo and Renata Esper Figueiredo are both reported as "Trustees" (IRS Form 990, Part VII, Section A). Cancer Care reports having 25 voting members on its governing body at the end of fiscal 2024, with all 25 members being independent (IRS Form 990, Part VI, Section A, lines 1a & 1b). |
